IGFBP3 and myocardial ischemia: With respect to IHD, an association between mortality and circulating concentrations of IGFBP-3, IGF-I, or IGF-II was also excluded by a large prospective Japanese study including more than 39,000 subjects between 40 and 79 years of age (47).